Dr Naiem Nassiri, MD | |
Yale University, 330 Cedar Street, Boardman Building 204, New Haven, CT 06510 | |
(818) 388-8899 | |
Not Available |
Full Name | Dr Naiem Nassiri |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 16 Years |
Location | Yale University, New Haven, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033366745 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Yale-new Haven Hospital | New haven, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Vascular Ct Pllc | 5890192884 | 5 |
Yale University | 9436061736 | 2241 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months and twelve months ended September 30, 2009. The Company reported a net loss of $746,000, or $0.02 per share, for the three months ended September 30, 2009 compared to a loss of $1,055,000, or $0.03 per share, for the three months ended September 30, 2008.
The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Winn-Dixie Stores, Inc. (WINN) today announced that it has partnered with Blue Cross and Blue Shield of Florida (BCBSF) to offer its customers Health Cards in all 353 of its Florida Winn-Dixie and Save-Rite locations.
Fears of contracting COVID-19 are preventing people accessing vital health services, experts say.
Although one of the most serious consequences of the Zika virus (ZIKV) in infants is microcephaly, there is a broad collection of anomalies now known as congenital Zika syndrome (CZS). Some of the most serious are ophthalmologic, including macular scarring, retinal defects, low visual acuity, strabismus, and nystagmus.
› Verified 3 days ago
Entity Name | Yale University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months and twelve months ended September 30, 2009. The Company reported a net loss of $746,000, or $0.02 per share, for the three months ended September 30, 2009 compared to a loss of $1,055,000, or $0.03 per share, for the three months ended September 30, 2008.
The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Winn-Dixie Stores, Inc. (WINN) today announced that it has partnered with Blue Cross and Blue Shield of Florida (BCBSF) to offer its customers Health Cards in all 353 of its Florida Winn-Dixie and Save-Rite locations.
Fears of contracting COVID-19 are preventing people accessing vital health services, experts say.
Although one of the most serious consequences of the Zika virus (ZIKV) in infants is microcephaly, there is a broad collection of anomalies now known as congenital Zika syndrome (CZS). Some of the most serious are ophthalmologic, including macular scarring, retinal defects, low visual acuity, strabismus, and nystagmus.
› Verified 3 days ago
Entity Name | Vascular Ct Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649943424 PECOS PAC ID: 5890192884 Enrollment ID: O20210917000350 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months and twelve months ended September 30, 2009. The Company reported a net loss of $746,000, or $0.02 per share, for the three months ended September 30, 2009 compared to a loss of $1,055,000, or $0.03 per share, for the three months ended September 30, 2008.
The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Winn-Dixie Stores, Inc. (WINN) today announced that it has partnered with Blue Cross and Blue Shield of Florida (BCBSF) to offer its customers Health Cards in all 353 of its Florida Winn-Dixie and Save-Rite locations.
Fears of contracting COVID-19 are preventing people accessing vital health services, experts say.
Although one of the most serious consequences of the Zika virus (ZIKV) in infants is microcephaly, there is a broad collection of anomalies now known as congenital Zika syndrome (CZS). Some of the most serious are ophthalmologic, including macular scarring, retinal defects, low visual acuity, strabismus, and nystagmus.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Naiem Nassiri, MD Yale University, 330 Cedar Street, Boardman Building 204, New Haven, CT 06510 Ph: (818) 388-8899 | Dr Naiem Nassiri, MD Yale University, 330 Cedar Street, Boardman Building 204, New Haven, CT 06510 Ph: (818) 388-8899 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months and twelve months ended September 30, 2009. The Company reported a net loss of $746,000, or $0.02 per share, for the three months ended September 30, 2009 compared to a loss of $1,055,000, or $0.03 per share, for the three months ended September 30, 2008.
The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Winn-Dixie Stores, Inc. (WINN) today announced that it has partnered with Blue Cross and Blue Shield of Florida (BCBSF) to offer its customers Health Cards in all 353 of its Florida Winn-Dixie and Save-Rite locations.
Fears of contracting COVID-19 are preventing people accessing vital health services, experts say.
Although one of the most serious consequences of the Zika virus (ZIKV) in infants is microcephaly, there is a broad collection of anomalies now known as congenital Zika syndrome (CZS). Some of the most serious are ophthalmologic, including macular scarring, retinal defects, low visual acuity, strabismus, and nystagmus.
› Verified 3 days ago
Gerard Andrew Betro, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Bldg, New Haven, CT 06519 Phone: 203-785-2140 Fax: 203-785-6414 | |
Dr. Vazrick Mansourian, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 136 Sherman Ave, Suite 308, New Haven, CT 06511 Phone: 203-776-5819 Fax: 203-772-7906 | |
Dr. Adrian Anthony Maung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar St # Bb310, Yale University School Of Medicine Section Of Trauma, New Haven, CT 06510 Phone: 203-785-3494 | |
Greta L Piper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar St # Bb310, New Haven, CT 06510 Phone: 203-785-2572 Fax: 209-785-3950 | |
Courtney Joan Gemmato, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 20 York St, Ynhh Dept Of Surgery, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Jerome Dwuan Taylor, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar St, New Haven, CT 06510 Phone: 929-210-6160 Fax: 929-210-6161 |